Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker NGNE
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Christine Mikail Cvijic President and CFO, Director | NGNE Neurogene Inc. | Sale | 4,200 | $36.13 | $151.7K Sale | Form 4 ↗ |
| Jul 6, 2026 | Christine Mikail Cvijic President and CFO, Director | NGNE Neurogene Inc. | Sale | 600 | $36.02 | $21.6K Sale | Form 4 ↗ |
| Jul 2, 2026 | Christine Mikail Cvijic President and CFO, Director | NGNE Neurogene Inc. | Sale | 1,530 | $35.23 | $53.9K Sale | Form 4 ↗ |
| Jul 2, 2026 | Christine Mikail Cvijic President and CFO, Director | NGNE Neurogene Inc. | Sale | 2,531 | $34.58 | $87.5K Sale | Form 4 ↗ |
| Jul 1, 2026 | Christine Mikail Cvijic President and CFO, Director | NGNE Neurogene Inc. | Sale | 739 | $34.06 | $25.2K Sale | Form 4 ↗ |
| May 6, 2026 | Christine Mikail Cvijic President and CFO, Director | NGNE Neurogene Inc. | Sale | 4,800 | $32.44 | $155.7K Sale | Form 4 ↗ |
| May 6, 2026 | Christine Mikail Cvijic President and CFO, Director | NGNE Neurogene Inc. | Sale | 4,800 | $30.07 | $144.3K Sale | Form 4 ↗ |
| Mar 26, 2026 | Julie Jordan Chief Medical Officer | NGNE Neurogene Inc. | Sale | 828 | $21.89 | $18.1K Sale | Form 4 ↗ |
| Mar 26, 2026 | Rachel McMinn Chief Executive Officer, Director | NGNE Neurogene Inc. | Sale | 3,352 | $22.07 | $74.0K Sale | Form 4 ↗ |
| Mar 26, 2026 | Christine Mikail Cvijic President and CFO | NGNE Neurogene Inc. | Sale | 2,558 | $21.62 | $55.3K Sale | Form 4 ↗ |
| Mar 13, 2026 | Stuart Cobb Chief Scientific Officer | NGNE Neurogene Inc. | Sale | 148 | $22.08 | $3,268 Sale | Form 4 ↗ |
| Mar 13, 2026 | Stuart Cobb Chief Scientific Officer | NGNE Neurogene Inc. | Sale | 2,658 | $21.34 | $56.7K Sale | Form 4 ↗ |
| Mar 13, 2026 | Stuart Cobb Chief Scientific Officer | NGNE Neurogene Inc. | Sale | 3,991 | $20.41 | $81.5K Sale | Form 4 ↗ |
| Mar 13, 2026 | Christine Mikail Cvijic President and CFO | NGNE Neurogene Inc. | Sale | 263 | $22.02 | $5,791 Sale | Form 4 ↗ |
| Mar 13, 2026 | Christine Mikail Cvijic President and CFO | NGNE Neurogene Inc. | Sale | 1,395 | $21.25 | $29.6K Sale | Form 4 ↗ |
| Mar 13, 2026 | Christine Mikail Cvijic President and CFO | NGNE Neurogene Inc. | Sale | 2,387 | $20.42 | $48.7K Sale | Form 4 ↗ |
| Feb 27, 2026 | Christine Mikail Cvijic President and CFO | NGNE Neurogene Inc. | Sale | 4,800 | $25.11 | $120.5K Sale | Form 4 ↗ |
| May 14, 2025 | Stuart Cobb Chief Scientific Officer | NGNE Neurogene Inc. | Sale | 6,797 | $15.15 | $103.0K Sale | Form 4 ↗ |
| Mar 13, 2025 | Christine Mikail Cvijic President and CFO | NGNE Neurogene Inc. | Sale | 4,501 | $16.94 | $76.2K Sale | Form 4 ↗ |
| Nov 26, 2024 | Srinivas Akkaraju 10% owner | NGNE Neurogene Inc. | Buy | 2,000 | $27.50 | $55.0K Buy | Form 4 ↗ |
| Nov 26, 2024 | Srinivas Akkaraju 10% owner | NGNE Neurogene Inc. | Buy | 15,219 | $26.73 | $406.8K Buy | Form 4 ↗ |
| Nov 26, 2024 | Srinivas Akkaraju 10% owner | NGNE Neurogene Inc. | Buy | 10,803 | $26.01 | $281.0K Buy | Form 4 ↗ |
| Nov 26, 2024 | Srinivas Akkaraju 10% owner | NGNE Neurogene Inc. | Buy | 20,748 | $24.91 | $516.8K Buy | Form 4 ↗ |
| Nov 22, 2024 | Christine Mikail Cvijic President and CFO | NGNE Neurogene Inc. | Buy | 24,000 | $20.48 | $491.5K Buy | Form 4 ↗ |
| Nov 22, 2024 | Rachel McMinn Chief Executive Officer, Director | NGNE Neurogene Inc. | Buy | 47,500 | $20.40 | $969.0K Buy | Form 4 ↗ |
25 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:44 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances